A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers – An analysis of GOG 218
Year: 2012
Type: article
Source: Gynecologic Oncology
Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Roswell Park Comprehensive Cancer Center, Creighton University, Duke Medical Center, Stanford Medicine, Harvard University, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, University of Arizona Cancer Center, Cleveland Clinic, Fox Chase Cancer Center
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2078786287